國家衛生研究院 NHRI:Item 3990099045/15700

NHRI > National Institute of Infectious Diseases and Vaccinology > Yee-Chun Chen > Periodical Articles > Item 3990099045/15700

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/15700

Title:	Global guideline for the diagnosis and management of cryptococcosis: An initiative of the ECMM and ISHAM in cooperation with the ASM
Authors:	Chang, CC;Harrison, TS;Bicanic, TA;Chayakulkeeree, M;Sorrell, TC;Warris, A;Hagen, F;Spec, A;Oladele, R;Govender, NP;Chen, SC;Mody, CH;Groll, AH;Chen, YC;Lionakis, MS;Alanio, A;Castañeda, E;Lizarazo, J;Vidal, JE;Takazono, T;Hoenigl, M;Alffenaar, JW;Gangneux, JP;Soman, R;Zhu, LP;Bonifaz, A;Jarvis, JN;Day, JN;Klimko, N;Salmanton-García, J;Jouvion, G;Meya, DB;Lawrence, D;Rahn, S;Bongomin, F;McMullan, BJ;Sprute, R;Nyazika, TK;Beardsley, J;Carlesse, F;Heath, CH;Ayanlowo, OO;Mashedi, OM;Queiroz-Telles Filho, F;Hosseinipour, MC;Patel, AK;Temfack, E;Singh, N;Cornely, OA;Boulware, DR;Lortholary, O;Pappas, PG;Perfect, JR
Contributors:	National Institute of Infectious Diseases and Vaccinology
Abstract:	Cryptococcosis is a major worldwide disseminated invasive fungal infection. Cryptococcosis, particularly in its most lethal manifestation of cryptococcal meningitis, accounts for substantial mortality and morbidity. The breadth of the clinical cryptococcosis syndromes, the different patient types at-risk and affected, and the vastly disparate resource settings where clinicians practice pose a complex array of challenges. Expert contributors from diverse regions of the world have collated data, reviewed the evidence, and provided insightful guideline recommendations for health practitioners across the globe. This guideline offers updated practical guidance and implementable recommendations on the clinical approaches, screening, diagnosis, management, and follow-up care of a patient with cryptococcosis and serves as a comprehensive synthesis of current evidence on cryptococcosis. This Review seeks to facilitate optimal clinical decision making on cryptococcosis and addresses the myriad of clinical complications by incorporating data from historical and contemporary clinical trials. This guideline is grounded on a set of core management principles, while acknowledging the practical challenges of antifungal access and resource limitations faced by many clinicians and patients. More than 70 societies internationally have endorsed the content, structure, evidence, recommendation, and pragmatic wisdom of this global cryptococcosis guideline to inform clinicians about the past, present, and future of care for a patient with cryptococcosis.
Date:	2024-08
Relation:	Lancet Infectious Diseases. 2024 Aug;24(8):e495-e512.
Link to:	http://dx.doi.org/10.1016/S1473-3099(23)00731-4
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1473-3099&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:001298955500001
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85184766931
Appears in Collections:	[Yee-Chun Chen] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP85184766931.pdf		708Kb	Adobe PDF	137	View/Open

Loading...